Clinical Trial Update: Study for Patients Previously Treated in Avapritinib Clinical Trials [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for patients previously treated with avapritinib in gastrointestinal stromal tumors has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Drugs mentioned

• AYVAKIT (avapritinib)

Snippet

Sponsor: Blueprint Medicines Corporation | Conditions: Gastrointestinal Stromal Tumors | Phase 4 | Status: COMPLETED | Results posted: 2024-11-26